Efficacy and Safety of Teclistamab Followed by Autologous Stem Cells Transplant in Functional High-Risk and Triple Class Refractory Multiple Myeloma. Mediterr J Hematol Infect Dis 2025, 17 (1), e2025051. https://doi.org/10.4084/MJHID.2025.051.